Physician profile
James A Gramm
NPI 1124084900
$385,519.90
in general payments reported to CMS, 2019-2025
13 companies · $5,175 in 2025
The $5,175 reported for 2025 was more than what 83% of Thoracic Surgery (Cardiothoracic Vascular Surgery) providers received nationally (typical 2025 total: $796).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $8,474 · 2020: $3,173 · 2021: $4,800 · 2022: $8,040 · 2023: $295K · 2024: $61K · 2025: $5,175.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $359K · Travel and Lodging: $1,647 · Food and Beverage: $362.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $359,025.00 |
| Travel and Lodging | $1,646.58 |
| Food and Beverage | $361.52 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Paragonix Technologies, INC. | $346,958.10 | 2023-2024 | Sherpacool Box, Paragonix Sherpapak Cardiac Transport System, Cts Canister Box |
| Abbott Laboratories | $34,645.00 | 2019-2025 | Mediguide, Sjm Masters Series |
| Baxter Healthcare | $2,310.00 | 2020 | |
| Covidien LP | $800.00 | 2019-2020 | |
| Ethicon INC. | $390.00 | 2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $158.91 | 2019-2020 | |
| E.R. Squibb & Sons, L.L.C. | $69.12 | 2019 | |
| Janssen Pharmaceuticals, INC | $62.59 | 2019 | |
| Medtronic, INC. | $40.00 | 2022 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $32.69 | 2019 | |
| Regeneron Healthcare Solutions, INC. | $30.18 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $12.09 | 2020 | |
| Sanofi-Aventis U.S. LLC | $11.22 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Gramm listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.